Number of Vials of Remdesivir, Tocilizumab and Amphotericin B Supplied for Treatment of COVID-19 Infections by Pharmaceutical Companies Against Allocation Given by Central Government in Jammu & Kashmir (As on 25.07.2021) | |||
UT | Remdesivir | Tocilizumab | Amphotericin B |
Jammu & Kashmir | |||
India |